The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
PHARMACOR MYCOPHENOLATE, MYCOCELL, ALCEPT (Pharmacor Pty Ltd)
Product name
PHARMACOR MYCOPHENOLATE, MYCOCELL, ALCEPT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
75 (255 working days)
Active ingredients
Mycophenolate mofetil
Registration type
New generic medicine
Indication
PHARMACOR MYCOPHENOLATE, MYCOCELL, ALCEPT is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants.
PHARMACOR MYCOPHENOLATE, MYCOCELL, ALCEPT is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.